Fuzionaire Diagnostics, Inc. Announces Name Change to Fuzionaire Theranostics, Inc. and Preclinical Oncology Pipeline
Fuzionaire Diagnostics, Inc. announced today that it has changed its name to Fuzionaire Theranostics, Inc. (“Fuzionaire Tx”).
- Fuzionaire Diagnostics, Inc. announced today that it has changed its name to Fuzionaire Theranostics, Inc. (“Fuzionaire Tx”).
- The HetSiFA® platform creates chemically identical diagnostic and therapeutic companions, a feature that enables a personalized therapeutic dose for each cancer patient.
- The name change marks a milestone in the company's growth plan and reflects a developing theranostic pipeline in oncology.
- The modularity of the HetSiFA platform enables the company to expand its pipeline rapidly with existing collaborators and new partners.